Dual Inhibitors Targeting DNA and Histone Deacetylases
Histone deacetylases (HDACs) regulate the acetylation status of histones and structural status of chromatin. The chromatin structure becomes relaxed after inhibition of HDAC, leading to DNA exposed to DNA disrupting agents, and eventually causing DNA dysfunction. Recently, more and more dual inhibit...
Saved in:
Main Authors: | Chen Chen (Author), Xinying Yang (Author), Xuben Hou (Author), Hao Fang (Author) |
---|---|
Format: | Book |
Published: |
Georg Thieme Verlag KG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting histone deacetylases for cancer therapy: Trends and challenges
by: Tao Liang, et al.
Published: (2023) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
by: Milan Beljkas, et al.
Published: (2023) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
by: Fabian B. Kraft, et al.
Published: (2023) -
Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
by: Danqi Chen, et al.
Published: (2016)